Connect with us

Hi, what are you looking for?

Tuesday, May 24, 2022
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.


Audacious and Golden Triangle open cannabis clinic in Thailand

Since opening in March, the firm says its clinic has already seen 800 patients

Audacious and Golden Triangle open cannabis clinic in Thailand
Photo via Herbidus Medical Center

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) — doing business as Audacious — says it’s partnered with Golden Triangle Health to open the first cannabis clinic in Thailand supported by an American operator.

Herbidus Medical Center opened its doors March 7 in Sukhumvit 13, Bangkok. The clinic has already seen close to 800 patients, according to Audacious.

Herbidus is among the first legal clinics to prescribe cannabis for government-approved treatment. Audacious will support the clinic with its expertise as well as white-label capabilities for product manufacturing.

Golden Triangle is owned by the Thai food manufacturer NR Instant Produce PCL, with a market cap close to $400 million.

“We believe that together, we can be one of the most important players in the Asian cannabis market, following our joint launch in the Asian CBD market earlier this year,” Golden Triangle co-founder Tom Kruesopon said in a statement.

Read more: Audacious says facility-building ALPS propped Q2 sales

Read more: Australis to help build massive produce facility in Kuwait

Audacious CEO Terry Booth says interest in medical cannabis is rising in Thailand, and his firm is looking forward to bringing cannabis expertise and leadership to the market.

“This is one of several initiatives that we are embarking on with Golden Triangle Health, which along with its parent company enjoys robust distribution channels across Thailand, as well as nimble and powerful white-label capabilities for cannabis product manufacturing,” he says.

Golden Health Triangle will receive support from Audacious chief science officer Jason Dyck, who is also a Canada Research Chair.

“This will leverage the years of research we have performed in Canada and other countries, including Dr. Dyck’s studies on one of the world’s largest databases of medical cannabis users to identify the primary reasons for medical cannabis authorization and the health outcomes of these patients,” Booth continues.

Read more: Why clinical cannabis research is so complex: Canada Research Chair Q&A

Read more: Terry Booth talks Aurora exit, new role as Australis CEO


Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Follow Natalia Buendia Calvillo on Twitter

Click to comment

Leave a Reply

Your email address will not be published.

You May Also Like

Health and Safety

Science doesn't know yet, but one psychedelic researcher is chasing clues to see if it can


As more medium-to-small producers came into play this year, great weed started hitting legal shelves at fairer prices


Punishments for possession include caning and the death penalty. Despite a global trend of reform, The Fine City remains staunch in its anti-drug stance


While legal weed businesses decry enforcement of their accounts, the platform says it's keeping its all-ages community safe